WellMet Study
Research area: Infection, Immunity and Global Health > Inflammatory Origins
Understanding the health and wellbeing among young people living with youth-onset type 2 diabetes (YT2D) or obesity, and the effects of new medications
The WellMet Study will evaluate the physical and psychological health of young people living with Youth Type 2 Diabetes and obesity, and investigate how GLP1RA and other similar medications may impact physical and psychological health over time
The WellMet Study will evaluate the physical and psychological health of young people living with Youth Type 2 Diabetes and obesity, and investigate how GLP1RA and other similar medications may impact physical and psychological health over time
The WellMet Study will evaluate the physical and psychological health of young people living with Youth Type 2 Diabetes and obesity, and investigate how GLP1RA and other similar medications may impact physical and psychological health over time
The challenge
Obesity and Type 2 Diabetes are increasing rapidly in Australia and around the world, including among children. New medications to manage obesity in adults has rapidly changed how health problems related to excess adiposity are managed. However, these medications are not easily accessible for children and youth, and more research is needed to understand how effective and safe they are in this age group
About WellMet
The WellMet Study will evaluate the physical and psychological health of young people living with Youth Type 2 Diabetes and obesity, and investigate how GLP1RA and other similar medications may impact physical and psychological health over time. This research will inform interventions that focus on improving long term health outcomes and quality of life.
Study details
The WellMet cohort will include 10-19 year olds recruited through specialised clinics at The Royal Children’s Hospital (RCH). Participants will attend three health visits over one year to assess:
- general health
- psychological health
- cardiovascular health
- anthropometry and fitness
- lung health
- vision
- hearing
- neurological health
- immune health
We also collect blood and urine samples to analyse markers of health.
Lead researchers
Our research is led by:
- Dr Danielle Longmore, Clinician Scientist Fellow, Inflammatory Origins, Infection, Immunity and Global Health
- Professor Dave Burgner, Group Leader, Inflammatory Origins, Infection, Immunity and Global Health
Funding and collaborations
Thanks to our key partners, funders, and supporters.
Funding
- The Royal Australasian College of Physicians Fellowship
- Clinical Scientist Fellowship, Murdoch Children’s Research Institute
Collaborators
- Christoph Saner, Department of Pediatric Endocrinology, Diabetology and Metabolism, University Children’s Hospital Bern, Switzerland
Contact us
For more information on the study, please contact us.
WellMet Study team
Phone:
show phone number
Email:
show email address
Cardiometabolic health news
MCRI’s 40th Anniversary Gala celebrates four decades of discovery
LIQUID Study: Lifecourse Quantification of Inflammation and Cardiometabolic Health
Jonathan Glenning awarded for childhood blood pressure screening program
Research Fellowship to advance insights into diabetes
Potential pathway linking infant infections to cardiovascular disease risk
Cardiometabolic health
Patients who are overweight or obese at risk of more severe COVID-19
Childhood obesity linked to poor heart health signs at 11-12 years
Children’s experiences of racial discrimination linked to risk markers of long-term chronic disease
Australians born through assisted reproduction technology are as healthy as other Aussies
Share //
